Table 2. Clinical Presentation and Course of Infants Admitted to the Intensive Care or High Acuity Unit With Respiratory Syncytial Virus Infection Stratified by Age Group in Months.
Clinical presentation and course | Infants, No. (%) | P valuea | |||
---|---|---|---|---|---|
Total (N = 600) | 0-2 mos (n = 323) | 3-5 mos (n = 127) | 6-11 mos (n = 150) | ||
Reason for admission | |||||
LRTI | 594 (99.0) | 317 (98.1) | 127 (100.0) | 150 (100.0) | .04 |
Apnea or bradycardia | 77 (12.8) | 67 (20.7) | 6 (4.7) | 4 (2.7) | <.001 |
Cardiac arrest at home with CPR | 3 (0.5) | 3 (0.9) | 0 | 0 | .14 |
CNS infection | 2 (0.3) | 2 (0.6) | 0 | 0 | .23 |
Shock requiring vasopressors | 5 (0.8) | 3 (0.9) | 1 (0.8) | 1 (0.7) | .75 |
Interventions within first 24 h | |||||
Highest level of respiratory supportb | |||||
None | 28 (4.7) | 16 (5.0) | 4 (3.1) | 8 (5.3) | .71 |
Low-flow supplemental oxygen | 51 (8.5) | 30 (9.3) | 6 (4.7) | 15 (10.0) | .96 |
High-flow nasal cannula oxygen | 252 (42.0) | 116 (35.9) | 71 (55.9) | 65 (43.3) | .03 |
Continuous positive airway pressure | 52 (8.7) | 34 (10.5) | 7 (5.5) | 11 (7.3) | .18 |
BiPAP/NIV | 114 (19.0) | 52 (16.1) | 24 (18.9) | 38 (25.3) | .02 |
Invasive mechanical ventilation | 103 (17.2) | 75 (23.2) | 15 (11.8) | 13 (8.7) | <.001 |
Cardiovascular support | 10 (1.7) | 6 (1.9) | 2 (1.6) | 2 (1.3) | .67 |
Vasopressors | 6 (1.0) | 3 (0.9) | 1 (0.8) | 2 (1.3) | .72 |
Clinical course | |||||
Highest level of respiratory support | |||||
None | 1 (0.2) | 1 (0.3) | 0 | 0 | >.99 |
Low-flow supplemental oxygen | 11 (1.8) | 5 (1.5) | 1 (0.8) | 5 (3.3) | .30 |
High-flow nasal cannula oxygen | 243 (40.5) | 114 (35.3) | 67 (52.8) | 62 (41.3) | .07 |
Continuous positive airway pressure | 52 (8.7) | 33 (10.2) | 7 (5.5) | 12 (8.0) | .30 |
BiPAP/NIV | 150 (25.0) | 69 (21.4) | 31 (24.4) | 50 (33.3) | .01 |
Invasive mechanical ventilation | 143 (23.8) | 101 (31.3) | 21 (16.5) | 21 (14.0) | <.001 |
Days ventilated, median (IQR) | 6 (4-10) | 6 (4-9) | 5 (3-10) | 7 (5-11) | .59 |
Vasopressor-dependent shock | 27 (4.5) | 19 (5.9) | 3 (2.4) | 5 (3.3) | .15 |
ECMO | 4 (0.7) | 2 (0.6) | 0 | 2 (1.3) | .53 |
Days in ICU, median (IQR)c | 3 (2-7) | 4 (2-8) | 3 (2-5) | 3 (2-6) | .002 |
Days in hospital, median (IQR)c | 5 (4-10) | 6 (4-12) | 5 (3-7) | 5 (3-8) | .001 |
In-hospital death | 2 (0.3) | 0 | 0 | 2 (1.3) | .11 |
Severity scores | |||||
pSOFA score, median (IQR) | 4 (3-4) | 4 (3-5) | 3 (3-4) | 3 (3-4) | <.001 |
PELOD-2 score, median (IQR) | 2 (1-4) | 2 (2-5) | 2 (0-4) | 0 (0-2) | <.001 |
PARDS criteria met | 120 (20.0) | 72 (22.3) | 21 (16.5) | 27 (18.0) | .19 |
Abbreviations: BiPAP, bilevel positive airway pressure; CNS, central nervous system; CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; LRTI, lower respiratory tract infection; NIV, noninvasive ventilation; PARDS, pediatric acute respiratory distress syndrome; PELOD, pediatric logistic organ dysfunction; pSOFA, pediatric sequential organ failure assessment.
Fisher exact test performed if any expected cell count was less than 5.
Data displayed reflect responses to a question as to whether the infant received mechanical ventilation and/or oxygen support during the first 24 hours of hospital admission. Low-flow supplemental oxygen and invasive mechanical ventilation were also noted at admission if reported on day 1 of daily clinical variables. This information may reflect pre–pediatric intensive care unit care.
A total of 598 survivors.